Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program



Status:Recruiting
Conditions:Prostate Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:19 - Any
Updated:2/13/2019
Start Date:June 1, 2015
End Date:February 2020

Use our guide to learn which trials are right for you!

The Effectiveness of a Proposed Prostate Cancer Outreach Program in a Predominantly African American Community That Promotes Informed Decision-making for Prostate Cancer Screening and Utilizes Community Navigation

This clinical trial studies an informed decision making intervention of screening for
prostate cancer in predominantly African American participants. It also evaluates
participants' knowledge about prostate cancer screening and to improve understanding. Using
decision aids such as culturally sensitive written material, verbal information, and videos
to educate patients about screening may increase patient participation and knowledge. This
may increase confidence in participants' decisions. Raising awareness about prostate cancer
in the communities may increase the participants' willingness to be screened for prostate
cancer once they have learned about it.

PRIMARY OBJECTIVES:

(A) To assess the effectiveness of a proposed educational model for informed decision about
Prostate Cancer in high risk men over age 40 which compares informed decision making and
shared decision making (B) to improve knowledge about prostate cancer in men over age 18

OUTLINE:

Participants complete an educational intervention comprising a 10-20 minute PowerPoint
presentation given by an experienced healthcare professional that discusses prostate cancer
facts, screening guidelines, risks, benefits, and consequences. Some participants then
undergo a screening exam comprising a prostate specific antigen level and digital rectal
exam.

After completion of study, participants are followed up periodically.

Inclusion Criteria:

- Men over the age of 18 will be asked to participate in the educational component of
the program; men over the age of 40 will be offered the screening component after the
educational portion of the event; participants over age of 40 will have the
opportunity to make an informed decision in regards to prostate cancer screening based
on this information and the educational material; American Cancer Society (ACS)
guidelines recommend having a discussion about screening in men who have an expected
mortality of greater than 10 years; data on comorbidities and 10-year mortalities will
be collected on every participant using the University of California at San Francisco
(UCSF) mortality index

- Educational component: men over the age of 18

- Screening component: men over age 40

Exclusion Criteria:

- Known personal history of prostate cancer

- Active malignancy, metastatic disease, or anyone undergoing treatment for malignancy
We found this trial at
1
site
11100 Euclid Avenue
Cleveland, Ohio 44106
216.844.8797
Principal Investigator: Samir Abraksia
Phone: 216-491-6438
Case Comprehensive Cancer Center The Case Comprehensive Cancer Center (Case CCC) based at Case Western...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials